Arai Ichiro
Department of Pharmaceutical Sciences, Nihon Pharmaceutical University.
Integr Med Res. 2021 Sep;10(3):100722. doi: 10.1016/j.imr.2021.100722. Epub 2021 Feb 21.
Japanese Kampo medicine is a traditional medicine with roots in ancient Chinese medicine. Because traditional physicians had been abolished in Japan, the present mainstream of Kampo treatment is that physicians who learned modern Western medicine prescribe Kampo extract products based on Western medical diagnosis. This situation is different from that in other east Asian countries, and the physicians require scientific clinical evidence.
Clinical studies were searched from literature databases, clinical trial registry sites, and "Evidence Reports of Kampo Treatment (EKAT)" published by the Japan Society for Oriental Medicine.
At the approval of Kampo products, scientific clinical evidence was not required because they have a long-period experience as a decoction. However, in the 1990s, Kampo products became a subject for national reevaluation; double-blind and placebo-controlled clinical trials. At the time, a methodological foundation for conducting clinical assessments of Kampo medicines was established. From 2000 onwards, with the evidence-based medicine era, the field of Kampo medicine also saw many randomized controlled trials, and their evidence was collected and published as EKAT. In the 2010s, post-marketing clinical trials of Kampo products also had to be conducted in this environment due to the need for ethical and scientific assurance. Currently, there are numerous clinical trials of Kampo products being conducted with high-grade trial designs.
The situation of Kampo clinical studies reflects the unique history and position of Kampo medical system and Kampo products in Japan.
日本汉方医学是一种起源于古代中医的传统医学。由于日本传统医师已被废除,目前汉方治疗的主流是学习现代西医的医师根据西医诊断开具汉方提取物产品。这种情况与其他东亚国家不同,医师们需要科学的临床证据。
从文献数据库、临床试验注册网站以及日本东洋医学会发表的《汉方治疗证据报告(EKAT)》中检索临床研究。
在汉方产品获批时,由于其作为煎剂有长期使用经验,所以不需要科学的临床证据。然而,在20世纪90年代,汉方产品成为国家重新评估的对象;进行了双盲和安慰剂对照临床试验。当时,建立了对汉方药物进行临床评估的方法学基础。从2000年起,随着循证医学时代的到来,汉方医学领域也出现了许多随机对照试验,其证据被收集并作为EKAT发表。在2010年代,由于需要伦理和科学保障,汉方产品的上市后临床试验也必须在这种环境下进行。目前,有许多采用高级试验设计的汉方产品临床试验正在开展。
汉方临床研究的情况反映了日本汉方医学体系和汉方产品独特的历史和地位。